Tina Zecca, DO
Allergy & Immunology · Little Silver, NJNPI 1790753630
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $173,432 of the $262,480 with a category attached, or 66.1%. It is spread thinly across 49 manufacturers, the largest accounting for just 23.9%. 2025 is the largest year on record at $71,363, 3.0 times the $23,571 reported in 2019. Among allergy & immunology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,550 payments — averaging $169.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$63K
- AstraZeneca$42K
- Grifols USA, LLC$40K
- Aimmune Therapeutics, Inc.$22K
- Kaleo, Inc.$14K
- ARS Pharmaceuticals Operations, Inc.$11K
- plus $71K from 43 others
Across 21 payments — averaging $6895.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$96K
- Kedrion S.p.a.$48K
What the payments were for
- Consulting fees$36,45214%
- Speaking & faculty fees$173,43266%
- Travel & lodging$19,9248%
- Food & beverage$32,47512%
- Education$1980%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$61,159
- Xembify$40,353
- TEZSPIRE$34,802
- PALFORZIA$21,266
- AUVI-Q$13,347
- NEFFY$11,078
- HYQVIA$8,273
- Ryaltris$6,533
- AYVAKIT$5,431
- OCTAGAM IMMUNE GLOBULIN (HUMAN)$4,545
- CUVITRU$4,475
- XOLAIR$4,107
- AIRSUPRA$3,295
- TAKHZYRO$2,454
- FASENRA$2,040
- Sajazir$1,220
- BREZTRI$1,130
- Rhapsido$1,083
- DUPIXENT$1,058
- Dust mite (D. farinae)$760
How this compares
$262,480 in reported general payments places this provider in the 95th percentile of 135 allergy & immunology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 47 | $175,923 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 67 | $151,580 |
| RydaptMidostaurin | 13 | $140,454 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 126 | $101,685 |
| Dupixent SyringeDupilumab | 12 | $56,699 |
| Breo ElliptaFluticasone/Vilanterol | 58 | $29,123 |
| XhanceFluticasone Propionate | 17 | $21,457 |
| Spiriva RespimatTiotropium Bromide | 22 | $18,824 |
| RyventCarbinoxamine Maleate | 28 | $17,464 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $15,294 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 87 | $14,154 |
| Advair HfaFluticasone Propion/Salmeterol | 31 | $12,545 |
| SymbicortBudesonide/Formoterol Fumarate | 33 | $11,668 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 35 | $11,073 |
| Arnuity ElliptaFluticasone Furoate | 39 | $10,123 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $689 | $151,58067 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $2,926 | $140,931223 claims |
| NovartisRydapt | $9,576 | $140,45413 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $42,462 | $26,96253 claims |
| Optinose US, Inc.Xhance | $62,655 | $21,45717 claims |
| Boehringer IngelheimSpiriva Respimat | $214 | $18,82422 claims |
| Hikma Pharmaceuticals USAEpinephrine | $6,620 | $7,88630 claims |
| Cycle Pharmaceuticals IncCromolyn Sodium | $1,308 | $1,79515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 135 allergy & immunology providers in New Jersey.
Other allergy & immunology in Little Silver
- Ellen SherOcean$1M
- Peter RickettiTrenton$457K
- John KimMedford$339K
- George BelecanechVoorhees$208K
- Jacqueline RossOcean$131K
- Shirin JadidiMendham$98K
- Mark WeinsteinBelleville$88K
- Joseph GrizzantiHawthorne$79K
- Lisa BariscianoFlorham Park$78K
- Kerry LebengerBerkeley Heights$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.